Informed consent is an ongoing communication process that helps a person decide whether to take part in research. It is more than a signature on a form. The research team must provide understandable information, answer questions, and support a voluntary decision. When consent is required, it is generally obtained before study-specific procedures begin.

What informed consent is designed to do

Informed consent reflects respect for each person's right to make decisions about participation. The process should explain why the research is being conducted, what will happen, how long participation may last, which procedures are experimental, and what choices exist outside the study. A potential participant should have enough time and opportunity to consider the information and ask questions without pressure or improper influence.

What the consent information commonly covers

The exact form depends on the study, but it commonly discusses the purpose of the research; expected visits, tests, treatments, questionnaires, or specimen collection; reasonably foreseeable risks and discomforts; possible benefits; alternatives; privacy and confidentiality; compensation or treatment for research-related injury when applicable; costs and payments; contact information; and the voluntary nature of participation. It should also explain circumstances in which participation may end.

Clinical-trial consent forms can be long because they document important details. Ask the team to define unfamiliar terms and explain information in a different way when needed. You may request a copy for review and, when appropriate, discuss it with family, trusted advisers, or your healthcare professional.

Signing does not remove your rights

Signing a consent form does not guarantee benefit, waive legal rights, or require a person to remain in the study. A participant may choose not to enroll or may later withdraw. The team can explain what steps are needed for a safe withdrawal, whether follow-up information may still be requested, and how information already collected may be handled under the consent form and applicable rules.

Consent continues during the study

Important new information may emerge while a study is underway, including new safety findings, changes to procedures, or information that may affect willingness to continue. The research team may provide updated information or ask participants to sign a revised consent form after appropriate review. Participants should continue asking questions throughout the study and promptly report symptoms or concerns through the contact process provided by the team.

Language, communication, and accessibility

Consent information should be presented in language understandable to the person considering participation. Tell the study team if you need an interpreter, translated materials, large print, a hearing or communication accommodation, or help understanding a document. Children and adults who cannot legally provide consent have additional protections; permission from a parent or legally authorized representative and assent from the participant may be involved depending on the situation and applicable requirements.

Questions to ask before deciding

• What is the main purpose of the study?
• Which treatments or procedures are investigational?
• What happens at each visit, and how much time is required?
• What risks are known, and what uncertainties remain?
• What benefits are reasonably possible, and might there be no direct benefit?
• What standard-care or non-study alternatives are available?
• What costs might I or my insurance be asked to pay?
• How will my medical information and samples be protected and used?
• Whom should I contact with questions, side effects, or urgent concerns?
• What happens if I decide to withdraw?

Take the time you need

A good consent conversation is clear, respectful, and unhurried enough for meaningful questions. Consider writing down questions and asking a trusted person to join the discussion if the study permits. Understanding the study does not obligate you to participate. The final decision belongs to the person being asked to volunteer or, when legally appropriate, an authorized representative.

Reliable sources

• HHS Office for Human Research Protections: Informed consent FAQs
• HHS OHRP: About research participation
• National Cancer Institute: Clinical trial information

This article provides general educational information and is not legal or medical advice. Requirements can depend on the study, applicable regulations, and individual circumstances. Ask the study team to explain the consent process for the specific protocol.